Total Payments
$47,495
2024 Payments
$9,137
Companies
13
Transactions
119
Payment Breakdown by Category
Other$24,375 (51.3%)
Consulting$11,125 (23.4%)
Travel$7,426 (15.6%)
Food & Beverage$2,853 (6.0%)
Research$1,715 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,375 | 8 | 51.3% |
| Consulting Fee | $11,125 | 4 | 23.4% |
| Travel and Lodging | $7,426 | 42 | 15.6% |
| Food and Beverage | $2,853 | 54 | 6.0% |
| Unspecified | $1,715 | 11 | 3.6% |
Payments by Type
General
$45,779
108 transactions
Research
$1,715
11 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $36,857 | 77 | $0 (2018) |
| Amgen Inc. | $7,704 | 15 | $0 (2024) |
| ABBVIE INC. | $1,715 | 11 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $264.81 | 3 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $219.77 | 2 | $0 (2018) |
| GENZYME CORPORATION | $113.35 | 1 | $0 (2017) |
| Medtronic MiniMed, Inc. | $103.31 | 1 | $0 (2017) |
| Novo Nordisk Inc | $101.68 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $93.80 | 1 | $0 (2021) |
| Radius Health, Inc. | $93.18 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,137 | 24 | Amgen Inc. ($7,359) |
| 2023 | $88.30 | 2 | Alexion Pharmaceuticals, Inc. ($49.10) |
| 2021 | $215.40 | 2 | Amgen Inc. ($121.60) |
| 2019 | $312.05 | 4 | Amgen Inc. ($223.25) |
| 2018 | $25,289 | 63 | Shire North American Group Inc ($24,864) |
| 2017 | $12,453 | 24 | Shire North American Group Inc ($11,994) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $62.48 | General |
| 04/12/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $796.37 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/12/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $69.00 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/12/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $50.54 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/12/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $37.50 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/11/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $226.86 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/11/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $125.05 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/11/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $70.25 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/11/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $50.54 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/11/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $37.50 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/11/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $25.00 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 04/10/2024 | ABBVIE INC. | ARMOUR THYROID (Drug) | — | In-kind items and services | $226.86 | Research |
| Study: A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism • Category: THYROID | ||||||
| 03/13/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | Cash or cash equivalent | $81.81 | General |
| Category: Bone Health | ||||||
| 03/13/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $38.00 | General |
| Category: Bone Health | ||||||
| 03/13/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $36.00 | General |
| Category: Bone Health | ||||||
| 02/21/2024 | Amgen Inc. | EVENITY (Biological) | Consulting Fee | Cash or cash equivalent | $5,960.00 | General |
| Category: Bone Health | ||||||
| 01/26/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $363.14 | General |
| Category: Bone Health | ||||||
| 01/26/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $238.49 | General |
| Category: Bone Health | ||||||
| 01/26/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $50.34 | General |
| Category: Bone Health | ||||||
| 01/26/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $39.75 | General |
| Category: Bone Health | ||||||
| 01/25/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.55 | General |
| Category: Bone Health | ||||||
| 01/25/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $119.25 | General |
| Category: Bone Health | ||||||
| 01/25/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $47.12 | General |
| Category: Bone Health | ||||||
| 01/24/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | In-kind items and services | $259.49 | General |
| Category: Bone Health | ||||||
| 05/05/2023 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $39.20 | General |
| Category: Growth Hormone | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism | ABBVIE INC. | $1,715 | 11 |
About Dr. Ranjodh Gill, M.D
Dr. Ranjodh Gill, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780612168.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ranjodh Gill, M.D has received a total of $47,495 in payments from pharmaceutical and medical device companies, with $9,137 received in 2024. These payments were reported across 119 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,375).
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Richmond, VA
- Active Since 06/28/2006
- Last Updated 07/22/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1780612168
Products in Payments
- NATPARA (Drug) $31,041
- EVENITY (Biological) $7,461
- ARMOUR THYROID (Drug) $1,715
- JARDIANCE (Drug) $177.35
- Prolia (Biological) $120.83
- SOTAGLIFLOZIN (Drug) $117.14
- DISEASE STATE (Drug) $113.35
- Strensiq (Drug) $103.35
- Minimed Paradigm Revel (Device) $103.31
- SOLIQUA (Drug) $102.63
- Tymlos (Biological) $93.18
- ClosureFast (Device) $50.90
- Sogroya (Biological) $39.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Richmond
Dr. Erica Kretchman, Do, DO
Endocrinology, Diabetes & Metabolism — Payments: $630,957
Endocrinology, Diabetes & Metabolism $630,957
Mrs. Shea Puttkammer, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $29,899
Endocrinology, Diabetes & Metabolism $29,899
Dr. Robert Adler, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $11,993
Endocrinology, Diabetes & Metabolism $11,993
Robert Castellucci, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $11,206
Endocrinology, Diabetes & Metabolism $11,206
Dr. Gregory Cook, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $6,266
Endocrinology, Diabetes & Metabolism $6,266
Colette Moussalli, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $5,667
Endocrinology, Diabetes & Metabolism $5,667